Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Sleeping Bruxism Treatment Market Share

ID: MRFR//3979-CR | 130 Pages | Author: Rahul Gotadki| December 2021

Sleep bruxism, characterized by the involuntary grinding and clenching of teeth during sleep, has emerged as a notable sleep-related movement disorder. Over recent years, the prevalence of this condition has witnessed a noticeable uptick, leading to various implications for individuals' oral health and overall well-being. This article explores the escalating prevalence of sleep bruxism, its impact on patients, and the burgeoning demand for therapeutic interventions, thus creating a conducive environment for market growth.

Prevalence Trends

According to a 2017 research article published in the Journal of Oral Rehabilitation, an assessment of the Dutch adolescent population revealed a prevalence of 4.2% for awake bruxism, with sleep bruxism ranging between 7.6% to 13.2%. These statistics underscore a substantial prevalence of the disorder, hinting at its increasing significance in contemporary healthcare discussions. As the numbers continue to rise, the associated complications, such as headaches and tooth wear attributed to sleep bruxism, are expected to follow suit.

Impact on Patients' Lives

The repercussions of sleep bruxism extend beyond the nocturnal realm, impacting patients' daily lives. Headaches and dental issues stemming from the persistent grinding and clenching can significantly compromise individuals' quality of life. The reported cases of these complications are anticipated to surge, creating a pressing need for effective therapeutic solutions to alleviate the burden on affected individuals.

Therapeutic Options and Demand Surge

In response to the escalating prevalence and associated complications, the demand for therapeutic options to manage sleep bruxism is on the rise. Medications, including antidepressants and muscle relaxants, have shown efficacy in mitigating symptoms associated with the disorder. Additionally, the utilization of mouthguards, designed to prevent teeth grinding and protect dental structures, has gained prominence as a preventive measure.

Administering Medications:
Medications such as antidepressants have demonstrated their effectiveness in managing the symptoms of sleep bruxism. By modulating neurotransmitters and altering the central nervous system activity, these medications aim to reduce the intensity and frequency of teeth grinding, providing relief to affected individuals.

Muscle Relaxants:
Muscle relaxants, another avenue of treatment, work by inhibiting muscle contractions, thereby preventing the excessive clenching associated with sleep bruxism. This approach addresses the physical manifestation of the disorder and aims to minimize the impact on dental structures and overall oral health.

Mouthguards:
The use of customized mouthguards represents a non-pharmacological intervention to protect teeth from the abrasive effects of grinding. These devices, often recommended by dental professionals, create a barrier between the upper and lower teeth, preventing direct contact and minimizing the risk of dental wear.

Market Growth Prospects

The escalating prevalence of sleep bruxism, coupled with the increasing awareness of its consequences, is set to propel the demand for therapeutic options. The market for sleep bruxism treatments is expected to witness substantial growth as individuals seek effective ways to manage and mitigate the impact of the disorder on their lives. The forecasted surge in reported cases of headaches and tooth wear due to sleep bruxism further accentuates the urgency for accessible and efficient therapeutic interventions.

Conclusion

As the prevalence of sleep bruxism continues to rise, the associated challenges and complications amplify the need for effective therapeutic solutions. Medications, muscle relaxants, and mouthguards represent viable options to manage the symptoms and mitigate the impact on patients' lives. The increasing demand for these treatments creates a favorable backdrop for the growth of the sleep bruxism treatment market. As healthcare professionals and researchers delve deeper into understanding the intricacies of this sleep-related movement disorder, innovative interventions and tailored solutions are expected to shape the landscape of sleep bruxism management in the foreseeable future.

User
Create this same content in 600 to 700 words:Mayo Foundation for the Medical Education and Research states that a majority of the sleep bruxism cases are reported amongst children. The grinding of teeth among toddlers happens when the top and bottom teeth are not aligned properly as well as to ease the pain incurred due to orofacial conditions. An increasing number of clinical trials recruiting children to study the effective ways to treat sleep bruxism is expected to fuel market growth. As of 20 August 2021, the following universities have initiated clinical trials related to sleep bruxism after January 2018, including Federal University of Pelotas, Brazil, Universidade Nove de Julho, Brazil, Cairo University, and Egypt Suleyman Demirel University, Kazakhstan. Similarly, WHO's current fact sheet on Oral Health states 530 million children suffer from dental caries of primary teeth. Moreover, African countries such as Niger, Angola, the Democratic Republic of Congo, and Mali have fertility rates higher than 5.6. Higher fertility rates in developing regions are expected to increase the child population. According to the US Census Bureau, the child population within the US is estimated to reach 74.7 million by 2023. With such growth patterns in the vulnerable child population, the estimated cases of sleep bruxism are projected to increase. This is stipulated to provide a significant driving force for the market to grow during the forecast period.
ChatGPT
Title: Emerging Trends in Sleep Bruxism: Focus on Pediatric Cases and Market Expansion

Introduction

Sleep bruxism, a condition characterized by teeth grinding during sleep, has shown a notable prevalence among children, according to the Mayo Foundation for Medical Education and Research. This article explores the specific impact of sleep bruxism on pediatric populations, the surge in clinical trials targeting children, and the anticipated market growth driven by these trends.

Pediatric Cases and Causes

The Mayo Foundation highlights that a majority of sleep bruxism cases are reported among children. In toddlers, teeth grinding often occurs due to misaligned top and bottom teeth or as a coping mechanism for orofacial conditions, potentially indicating an attempt to alleviate pain. Understanding and addressing sleep bruxism in children are crucial for preventing long-term dental complications and improving overall well-being.

Clinical Trials and Market Growth

An encouraging development in the field is the increasing number of clinical trials focusing on children to study effective ways of treating sleep bruxism. This surge in research is anticipated to play a pivotal role in market growth. As of August 20, 2021, several universities worldwide, including the Federal University of Pelotas and Universidade Nove de Julho in Brazil, Cairo University in Egypt, and Suleyman Demirel University in Kazakhstan, have initiated clinical trials related to sleep bruxism after January 2018. This global research effort underscores the recognition of the significance of addressing sleep bruxism in pediatric populations.

Global Trends and WHO's Perspective

According to the World Health Organization (WHO), their current fact sheet on Oral Health reveals that 530 million children globally suffer from dental caries in their primary teeth. The burden of oral health issues among children is a global concern, and addressing conditions like sleep bruxism is integral to comprehensive pediatric dental care.

Moreover, fertility rates in certain African countries, such as Niger, Angola, the Democratic Republic of Congo, and Mali, are reported to be higher than 5.6. Higher fertility rates contribute to an increased child population in these developing regions. The United States Census Bureau estimates that the child population within the U.S. is expected to reach 74.7 million by 2023. These demographic patterns signal a growing vulnerable child population susceptible to sleep bruxism, creating a demand for effective treatments.

Projected Increase in Sleep Bruxism Cases

With the anticipated growth in the vulnerable child population globally, the prevalence of sleep bruxism is projected to increase. The link between misaligned teeth, orofacial conditions, and teeth grinding in children suggests a need for targeted interventions to address the root causes of sleep bruxism in this demographic. As cases of sleep bruxism rise in tandem with the expanding child population, there is a substantial driving force for the market to grow during the forecast period.

Conclusion

The increasing prevalence of sleep bruxism among children, as highlighted by the Mayo Foundation, necessitates a comprehensive understanding of the condition's impact on pediatric populations. The surge in clinical trials and global research efforts targeting children indicates a recognition of the importance of addressing sleep bruxism early in life. As demographic trends point toward a growing vulnerable child population, the market for sleep bruxism treatments is poised for significant expansion. This intersection of healthcare trends, research initiatives, and demographic shifts underscores the evolving landscape of sleep bruxism management, with a focus on providing effective solutions for the pediatric demographic.

Covered Aspects:

Report Attribute/Metric	Details
Base Year For Estimation	2020
Historical Data	2018 & 2019
Forecast Period	2023-2032
Growth Rate	6%

Sleeping Bruxism Treatment Market Highlights:

Sleeping Bruxism Treatment Market Trends

Sleeping Bruxism Treatment Market Analysis

Sleeping Bruxism Treatment Market Share

Sleeping Bruxism Treatment Companies

Sleeping Bruxism Treatment Market Overview:

Sleeping Bruxism Treatment Market size is projected to be worth USD 1.03 Billion by 2032, registering a CAGR of 6% during the forecast period (2023 - 2032)

Sleeping bruxism is a chronic sleep related movement disorder which is characterized by clenching of the jaw, teeth and cheek during sleep. The common symptom of this disease is tooth wear on the upper front teeth. It can also cause soreness in the neck muscle and headaches. The treatment of sleep bruxism includes holding dental guard to keep patient mouth closed during sleep which reduces risk of anxiety or stress.

The growth of the global sleeping bruxism treatment market is attributed to the increasing prevalence of sleep bruxism, growing child population, rising prevalence of obstructive sleep apnea and lifestyle changes. However, limited availability of treatment options is hampering the market growth. Also, untapped markets in Asia-Pacific provide viable opportunities for market growth in the future.

COVID-19 Analysis

The stress caused due to variable factors during the pandemic increased the demand for sleeping bruxism treatment. The health experts found that stress, anxiety, insomnia are the major factors that augmented the number of sleeping bruxism cases. Sleeping bruxism may lead to tooth fractures in serious cases. Moreover, the dental appointments and consulting services rose in the mid of the pandemic as a large number of the patients were experiencing pain and teeth grinding issues. These factors accelerated the demand for sleeping bruxism treatment across the world. However, improvement in networking and communication infrastructure supported the telehealth platforms, thereby helping patients and doctors in face-to-face consulting. The hospitals, dental clinics, and ambulatory centers are functional for emergency cases such as immediate discomfort in the jaw joints, tooth fractures, and increased agony in the facial muscular worldwide. Hence, there is a rise in the immediate sleeping bruxism treatment, including injections, anti-anxiety/anti-depressants drugs, bite guards, nonsteroidal anti-inflammatory drugs (NSAIDs), and heat packs.

A chronic movement disorder associated with sleep called sleeping bruxism is characterized by nighttime jaw, tooth, and cheek clenching. Stress on the upper teeth is a typical sign of this illness. Additionally, headaches and neck muscular discomfort may result from it. Using a dental guard to keep the patient's mouth shut while they sleep can help treat sleep bruxism and lower their risk of worry or tension. The expansion of this market is attributed to the fact that it is an emerging market and to the significant investments made in research & development. Sleep Treatment for bruxism necessitates a multidisciplinary approach, and growing consumer awareness of oral health is encouraging for business.

The dental diagnostics market related to sleep bruxism would benefit from greater awareness of the advantages of prompt identification of sleep bruxism to prevent harm to the facial and oral structures. Globally high healthcare costs also contribute to the market's expansion. Broken or loose dental fillings, a dull headache, discomfort in the face, damaged teeth, discomfort in the jaw, and other symptoms are just a few of the many signs and symptoms of bruxism. When teeth are growing, it is prevalent in young children. Researchers have discovered that taking drugs to treat bruxism is not particularly successful. As a result, they are working to promote preventative measures to manage this disorder's effects. It calls for using occlusal splints, mandibular progression tools, stress reduction tools, and similar tools.

Various drugs and muscle relaxants are employed to treat sleep bruxism. However, there are several negative effects that these drugs might have, including constipation, nausea, and muscle weakness. In addition, mouth guards for bruxism frequently wore down over time. The absence of viable treatment alternatives may thus restrain the expansion of the global sleep bruxism market. Stress is another major factor in adult bruxism. Caffeine and alcohol use can also cause bruxism. Some people experience it when a tooth is missing, or their bite is out of alignment. Vitamin C helps patients better respond to stress and control their moods, but a B-vitamin deficit can lead to bruxism-related symptoms like panic attacks, tension, and sadness. Vitamin B5 has been scientifically linked to a stable mood, which is beneficial for treating bruxism. Additionally, the increasing prevalence of the sleep bruxism problem spurs market expansion. Since children are typically the group most impacted by this disorder, increasing the number of children would boost market demand.

Sleeping Bruxism treatment Market Trends

Increasing prevalence of sleeping bruxism
- Since the past few years, the prevalence of sleeping bruxism has increased. A research article was published in 2017 in the Journal of Oral rehabilitation assessing the Dutch adolescent population. It mentioned the prevalence of 4.2% for awake bruxism and sleep bruxism in the range of 7.6% to 13.2%. In the presence of such trends, the reported cases of headaches and tooth wear due to sleep bruxism are estimated to increase, thereby mounting a negative impact on the patients' lives. Few effective ways to avoid such complications associated with the disease include administering medications, antidepressants, and muscle relaxants and wearing a mouthguard. Thus, the increasing prevalence of sleeping bruxism is subsequently increasing the demand for the available therapeutic options. Conclusively, it is expected to provide favorable backgrounds for the market to grow during the forecast period.

Growing child population

Rising prevalence of obstructive sleep apnea

Lifestyle changes

Market Restraints

Limited Availability of Treatment Options
- Medications are not very effective for treating sleeping bruxism. In such circumstances, it becomes important to manage the consequences of the disorder by the available preventative measures, which involve the application of mandibular advancement devices, occlusal splints, stress management, drugs, occlusal splints, and others. A variety of medications, such as anti-anxiety drugs and muscle relaxants, are significantly employed to treat sleeping bruxism. However, it is reported that such medication options come with the capping of side effects such as constipation, nausea, and muscle weakness, amongst others. Following the same course, it is evident that bruxism mouthguards ground down with time during bruxism episodes. Thus, it is estimated that the available treatment options are not effective and incorporates side effects, making the patients reluctant to opt for the available treatment options.

Market Opportunities

Untapped Markets in Asia-Pacific

The markets in Asia-Pacific have a relatively low penetration for sleep bruxism products. In recent years, the healthcare sector within the region has witnessed huge investments, thereby expanding the dental industries in developing economies such as India, China, and Australia. The overall Indian healthcare industry has witnessed a rapid change backed by the rising demand for superior quality healthcare products in the country. According to the World Dental Show in 2017, the Indian dental industry was estimated to reach USD 242.81 million at a positive CAGR of 16.0% by the end of 2018. Such growth in the dental industry is estimated to be seen as an opportunity by market players to launch new and technologically advanced products within the regional boundaries of Asia-Pacific region. Moreover, many cases of sleeping bruxism occur in comorbid conditions with Obstructive Sleep Apnea (OSA). In 2018, according to the SNORE AUSTRALIA, ~9.0% of women and 25.0% of men in Australia had clinically significant obstructive sleep apnea. Value Chain Analysis

The global sleeping bruxism treatment market is showing positive growth, owing to the increasing workplace stress, changing lifestyle, and rising prevalence of obstructive sleep disorders such as sleep apnea, insomnia, and excessive sleepiness. The value chain analysis for the market comprises four major components, which start with the research & development and product designing, manufacturing, distribution & sales and post-sales review.

Sleeping Bruxism Treatment Market Segment Insights

Sleeping Bruxism Treatment Type Insights

Primary Bruxism
- Primary bruxism occurs in the absence of any medical condition. It is associated with social psychological factors, dysfunction of the basal ganglia, tooth interference, and genetic influences. In primary bruxism, chewing muscle activity and the autonomic nervous system is triggered by sleep arousals that eventually lead to teeth grinding.

Secondary Bruxism
- Secondary bruxism occurs in the presence of some neurological disorder, medical or psychiatric condition, or due to a side effect of drugs. Sleeping bruxism is highly found in people who consume psychoactive substances. According to the CDC, from 2015 to 2018, around 13.2% of adults used antidepressants; higher use was seen among women, around 17.7% than men, which is around 8.4%. According to the National Institute of Neurological Disorders and Stroke, there are more than 600 neurologic disorders, with approximately 50 million Americans affected each year.

Sleeping Bruxism Treatment Cause Insights

Obstructive Sleep Apnea
- According to National Sleep Foundation, one in four people with Obstructive Sleep Apnea (OSA) clench their teeth in sleep. A research article published in the Journal of Clinical Medicine in 2019 carried out a study to understand the relationship between OSA and sleep disorders such as sleeping bruxism. The study concluded that there was a relationship between OSA and Sleep Bruxism (SB) that also depends on the degree of severity of OSA.

Gastroesophageal Reflux Disease (GERD)
- Gastroesophageal Reflux Disease (GERD) is a digestive disorder that affects the population of every age, from infants to older adults. Sleep bruxism is commonly observed in GERD patients; sleep apnea causes gastric acid to leak into the esophagus, which further triggers micro-arousals, eventually leading to sleep bruxism. A data published in 2018 in PubMed describes the association between GERD and patients with sleep bruxism (SB). Bruxism is strongly associated with GERD patients with frequent bruxism symptoms. Such association between GERD and SB is fueling the market growth of this segment.

Malocclusion
- Malocclusion is a misalignment of teeth caused due to childhood habits such as thumb sucking and imposes functional and aesthetic disturbances. According to an article published in 2020, the etiology of bruxism is multifactorial; that is, it is the combination of local, systemic, psychological, occupational, and hereditary factors. The article studied the prevalence of sleep bruxism and reported that the prevalence of sleep bruxism was 22% in the study population and was associated with malocclusions. Such studies focused on understanding the association between sleep bruxism and malocclusion is driving this segment's growth.

Sleep Paralysis
- Sleep Paralysis (SP) is linked with sleeping bruxism, and patients tend to grind their teeth if they have a sleeping disorder such as sleep talking, sleep paralysis, and sleep hallucinations. According to CDC, the sleep paralysis can affect around 7.6% of the general population during their lifetime, and it is a common condition worldwide. Hence, the increasing prevalence of sleep paralysis and its association with sleep bruxism is boosting the growth of this segment.

Sleeping Bruxism Treatment Treatment Insights

Dental Approaches
- Dental approaches are the first-line treatment given to sleeping bruxism patient and includes splints and mouth guards. Mouth guards help to reduce the pressure on the jaw and teeth whereas occlusal splints are used to prevent primary sleep bruxism. Splints cover the whole maxillary or mandibular dental arch that reduces the masticatory events per hour of sleep. The dental approach also includes dental correction.

Medication
- On the basis of its type of medication, the global sleep bruxism market is segmented into muscle relaxants, injections, and anti-anxiety drugs. Muscle relaxant treatment includes injecting the muscle relaxant into the masseter muscle, which weakens the muscle and eventually reduces the grinding of teeth. Treatment with Botulinum Toxin Type A is treatment and relieves the patient from jaw soreness, headaches, and other problems of bruxism. A small amount of injected into the masseter muscle which weakens the muscle and prevents the involuntary grinding of teeth.

Sleeping Bruxism Treatment Patient Type Insights

Americas

The Americas accounted for the largest market share in 2020 in the global sleeping bruxism treatment market, owing to the rising prevalence of sleeping bruxism, rising stress and anxiety among the population

According to the Anxiety & Depression Association of America, anxiety disorders affect about 40 million adults in the US, or 18.1% of the population every year. Moreover, according to the National Institutes of Health, more than 40 million Americans suffer from chronic, long-term sleep disorders, and an additional 20 million report sleeping problems occasionally. Furthermore, the American Sleep Association estimates that sleeping bruxism affects 10% of the adult population and 15% of the children population. Hence, the Americas market is expected to reach USD 318.70 million by 2027 at a CAGR of 6.47% from 2021–2027.

Asia-Pacific

Asia-Pacific is expected to grow rapidly in the sleeping bruxism treatment market owing to the growing adoption of advanced healthcare technology and rising child population

According to UNICEF, in 2016, South Asia has 627 million children, i.e., 36% of the total population. Moreover, raising awareness of sleep bruxism and rapidly growing dental industry in countries such as China, India, Japan, and South Korea is likely to fuel the market growth. Furthermore, there has been a growing prevalence of mental illness, including stress, anxiety, and depression, and sleep-related disorders such as sleep apnea in the region. These factors contribute to market growth in Asia-Pacific region. A study included a sample of twenty-two individuals with masseter muscle pain and tooth sensitivity due to their teeth' deterioration from nocturnal bruxism. The sample was split into two groups at random. 11 patients in the Botox (BO) group received 10 MU of BTXA injections, and 11 patients in the placebo (PL) group received a phony treatment. The effectiveness of this treatment approach for nocturnal bruxism was evaluated using visual analog scales to measure pain perception and electromyography (EMG) to record muscle activity.

Competitive Landscape

The global sleeping bruxism treatment market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.

List of companies with HQ

Ivoclar Vivadent AG (Liechtenstein)

Ipsen S.A. (France)

Merz Pharma GmbH & Co. KGaA (Germany)

Carestream Dental (US)

Akervall Technologies Inc (US)

Planmeca Oy (Finland)

Randmark Dental Products, LLC (US)

S4S (UK) Limited (UK)

Patterson Dental Supply, Inc (US)

Henry Schein, Inc (US)

Pfizer, Inc (US)

Recent Developments

In January 2021, Henry Schein, Inc. acquired majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies. With this transaction, Henry Schein Medical, the US medical division of Henry Schein, Inc., enters an established and growing multibillion-dollar market for home medical equipment and supplies.

In June 2020, Carestream Dental entered into a partnership with Unified Smiles, a management consulting firm based in the US. Under the partnership, Carestream Dental will provide support, guidance, and education to independent practices.

Report Overview

The study covers the existing short-term and long-term market effects. It helps decision-makers to draught short-term and long-term business plans by region. The report covers major regions in Americas, Europe, Asia-Pacific, and the Middle East and Africa. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the market.

Study Objectives

To provide a comprehensive analysis of the global sleeping bruxism treatment market and its sub-segments, thereby providing a detailed structure of the industry

To provide detailed insights into factors driving and restraining the growth of the global sleeping bruxism treatment market

To estimate the market size of the sleeping bruxism treatment market where 2018 to 2019 would be the historical period, 2020 shall be the base year, and forecast period for the study

To provide strategic profiling of key companies (manufacturers and distributors) present across the countries, and comprehensively analyze their competitiveness/competitive landscape in this market

To provide a value chain analysis for the sleeping bruxism treatment market

Sleeping Bruxism Treatment Market Segmentation

Sleeping Bruxism Treatment Type Outlook

Primary Bruxism

Secondary Bruxism

Sleeping Bruxism Treatment Cause Outlook

Obstructive Sleep Apnea

Gastroesophageal reflux disease (GERD)

Malocclusion

Sleep Paralysis

Sleeping Bruxism Treatment Treatment Outlook

Dental Approaches
- Mouth Guard
- NTI-TSS Device

Medication

Muscle Relaxants

Botulinum toxin type A Injections

Anti-anxiety Drugs

Sleeping Bruxism Treatment Market Patient Type Outlook

Pediatric

Adult
- Male
- Female

Sleeping Bruxism Treatment End User Outlook

Hospitals & Clinics

Dental Clinics

Sleeping Bruxism Treatment Region Outlook

Americas
- US
- Canada

South America

Europe
- Western Europe
  - Germany
  - France
  - UK
  - Scandinavia
  - Benelux Union
  - Italy
  - Spain
  - Switzerland
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East and Africa
- Middle East
- Africa

Intended Audience

Manufacturers and distributors

Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

Research institutes

Contract Manufacturing Organizations (CMOs)

Government associations

Market research and consulting firms

Venture capitalists and investors

- Sleep bruxism occurs in children when they are deep in sleep and are under stress. Additionally, anger and nervousness lead to bruxism in kids. According to Kids Health, 3 out of every ten children suffer from sleep bruxism. Moreover, as stated by the Journal of Family Medicine and Primary Care in 2020, sleep bruxism is a frequent parasomnia encountered by children. The increasing pediatric population suffering from sleep bruxism is boosting the market growth of this segment.

Adult
- Awake bruxism and sleep bruxism are common conditions found among adult populations. Also, women reported both awake bruxism and sleep bruxism more often than men. Sleep bruxism affects males and females in equal proportions. Sleep bruxism in adults is mainly caused due to anxiety, alcohol consumption, cigarette smoking, stress, caffeine, obstructive sleep apnea, and fatigue. The increasing adult population suffering from bruxism is fueling the market growth of this segment.

Sleeping Bruxism Treatment End User

Hospitals & Clinics
- With developing medical technology, hospitals and clinics are providing treatments such as consultation, psychoanalysis, and progressive relaxation. Hospitals and clinics carry out a diagnosis of sleep bruxism as they carry out a clinical examination, electromyographic recordings, and imaging. Hospitals and clinics dominate the global market due to increasing demands for the treatment of sleep bruxism.

Dental Clinics
- Dental clinics offer mouth guards, splints, orthodontic treatment, and dental corrections. The increasing use of teeth restoration in dental clinics accounts for a major market share in the sleep bruxism treatment market. Moreover, the increasing prevalence of dental problems such as malocclusion and teeth grinding during sleep have also increased the number of dental clinics involved in treating sleeping bruxism, which contributes to market growth in this segment.

Regional AnalysisFigure: GLOBAL SLEEPING BRUXISM TREATMENT MARKET SHARE (%), BY Region,

Americas

The Americas accounted for the largest market share in 2020 in the global sleeping bruxism treatment market, owing to the rising prevalence of sleeping bruxism, rising stress and anxiety among the population

According to the Anxiety & Depression Association of America, anxiety disorders affect about 40 million adults in the US, or 18.1% of the population every year. Moreover, according to the National Institutes of Health, more than 40 million Americans suffer from chronic, long-term sleep disorders, and an additional 20 million report sleeping problems occasionally. Furthermore, the American Sleep Association estimates that sleeping bruxism affects 10% of the adult population and 15% of the children population. Hence, the Americas market is expected to reach USD 318.70 million by 2027 at a CAGR of 6.47% from 2023-3032.

Asia-Pacific

Asia-Pacific is expected to grow rapidly in the sleeping bruxism treatment market owing to the growing adoption of advanced healthcare technology and rising child population

According to UNICEF, in 2016, South Asia has 627 million children, i.e., 36% of the total population. Moreover, raising awareness of sleep bruxism and rapidly growing dental industry in countries such as China, India, Japan, and South Korea is likely to fuel the market growth. Furthermore, there has been a growing prevalence of mental illness, including stress, anxiety, and depression, and sleep-related disorders such as sleep apnea in the region. These factors contribute to market growth in Asia-Pacific region.

Competitive Landscape

The global sleeping bruxism treatment market is characterized by the presence of many global, regional, and local vendors. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, quality, and reliability. It is decisive for the vendors to provide cost-efficient and high-quality products to survive and succeed in an intensely competitive market environment.

List of companies with HQ

Ivoclar Vivadent AG (Liechtenstein)

Ipsen S.A. (France)

Merz Pharma GmbH & Co. KGaA (Germany)

Carestream Dental (US)

Akervall Technologies Inc (US)

Planmeca Oy (Finland)

Randmark Dental Products, LLC (US)

S4S (UK) Limited (UK)

Patterson Dental Supply, Inc (US)

Henry Schein, Inc (US)

Pfizer, Inc (US)

Recent Developments

In January 2021, Henry Schein, Inc. acquired majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies. With this transaction, Henry Schein Medical, the US medical division of Henry Schein, Inc., enters an established and growing multibillion-dollar market for home medical equipment and supplies.

In June 2020, Carestream Dental entered into a partnership with Unified Smiles, a management consulting firm based in the US. Under the partnership, Carestream Dental will provide support, guidance, and education to independent practices.

Report Overview

The study covers the existing short-term and long-term market effects. It helps decision-makers to draught short-term and long-term business plans by region. The report covers major regions in Americas, Europe, Asia-Pacific, and the Middle East and Africa. The report analyzes market drivers, restraints, opportunities, challenges, Porter's five forces, value chain, and impact of COVID-19 on the market.

Study Objectives

To provide a comprehensive analysis of the global sleeping bruxism treatment market and its sub-segments, thereby providing a detailed structure of the industry

To provide detailed insights into factors driving and restraining the growth of the global sleeping bruxism treatment market

To estimate the market size of the sleeping bruxism treatment market where 2018 to 2019 would be the historical period, 2020 shall be the base year, and 2021 to 2027 will be forecast period for the study

To provide strategic profiling of key companies (manufacturers and distributors) present across the countries, and comprehensively analyze their competitiveness/competitive landscape in this market

To provide a value chain analysis for the sleeping bruxism treatment market.

Market Segmentation:Global Sleeping Bruxism Treatment Market, By Type

Primary Bruxism

Secondary Bruxism

Global Sleeping Bruxism Treatment Market, By Cause

Obstructive Sleep Apnea

Gastroesophageal reflux disease (GERD)

Malocclusion

Sleep Paralysis

Global Sleeping Bruxism Treatment Market, By Treatment

Dental Approaches
- Mouth Guard
- NTI-TSS Device

Medication

Muscle Relaxants

Botulinum toxin type A Injections

Anti-anxiety Drugs

Global Sleeping Bruxism Treatment Market, By Patient Type

Pediatric

Adult
- Male
- Female

Global Sleeping Bruxism Treatment Market, By End User

Hospitals & Clinics

Dental Clinics

Global Sleeping Bruxism Treatment Market, By Region

Americas
- US
- Canada

South America

Europe
- Western Europe
  - Germany
  - France
  - UK
  - Scandinavia
  - Benelux Union
  - Italy
  - Spain
  - Switzerland
  - Rest of Western Europe
- Eastern Europe

Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific

Middle East and Africa
- Middle East
- Africa

Intended Audience

Manufacturers and distributors

Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)

Research institutes

Contract Manufacturing Organizations (CMOs)

Government associations

Market research and consulting firms

Venture capitalists and investors

Sleeping Bruxism Treatment Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions